CA Patent

CA3139865A1 — Treatment of infantile hemangioma

Assigned to Pediatric Derm Developement LLC · Expires 2020-12-03 · 5y expired

What this patent protects

Transdermal delivery of beta blockers to treat Infantile Hemangiomas.

USPTO Abstract

Transdermal delivery of beta blockers to treat Infantile Hemangiomas.

Drugs covered by this patent

propranolol-hydrochloride (PROPRANOLOL HYDROCHLORIDE)

Patent Metadata

Patent number: CA3139865A1
Jurisdiction: CA
Classification: —
Expires: 2020-12-03
Drug substance claim: No
Drug product claim: No
Assignee: Pediatric Derm Developement LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.